InMed Pharmaceuticals Inc. (INM) Earnings Call Transcripts
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 18 calls on record spanning February 14, 2020 to May 19, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 18 InMed Pharmaceuticals Inc. earnings call transcripts on record, spanning February 14, 2020 to May 19, 2026. Based on this history, InMed Pharmaceuticals Inc. reports semi-annually. The most recent call on file is dated May 19, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- INM
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 18
- First call
- February 14, 2020
- Most recent
- May 19, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| M&A Calls | May 19, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Dec 18, 2025 | Read transcript → |
| Shareholder/Analyst Calls | Jun 13, 2025 | Read transcript → |
| Shareholder/Analyst Calls | Dec 19, 2024 | Read transcript → |
| Special Calls | Nov 12, 2024 | Read transcript → |
| Special Calls | Jan 25, 2024 | Read transcript → |
| Shareholder/Analyst Calls | Dec 19, 2023 | Read transcript → |
| Special Calls | Jul 25, 2023 | Read transcript → |
| Special Calls | May 31, 2023 | Read transcript → |
| Shareholder/Analyst Calls | Dec 15, 2022 | Read transcript → |
| Q2 FY2022 | Feb 15, 2022 | Read transcript → |
| Shareholder/Analyst Calls | Dec 17, 2021 | Read transcript → |
| Earnings Calls | Sep 24, 2021 | Read transcript → |
| Q3 FY2021 | May 13, 2021 | Read transcript → |
| Q2 FY2021 | Feb 11, 2021 | Read transcript → |
| Earnings Calls | Sep 8, 2020 | Read transcript → |
| Q3 FY2020 | May 14, 2020 | Read transcript → |
| Q2 FY2020 | Feb 14, 2020 | Read transcript → |